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Importance 
American trypanosomiasis (Chagas disease) is an important cause of heart 
disease, megaesophagus and megacolon among people in Mexico, Central and South 
America. Many mammals can be infected with the parasite that causes this disease; 
however, among animals, clinical cases have been reported mainly in dogs. Chagas 
disease is transmitted by the bites of triatomine insects, or “kissing bugs.” Some 
infected insects occur in sylvatic environments, where humans are exposed only 
occasionally. These “sylvatic cycles” are found from the U.S. through South America. 
From Mexico through South America, triatomine insects have also become adapted to 
human dwellings, particularly substandard housing where the insects hide in cracks 
during the day and emerge to feed on humans and animals at night. Most human cases 
are acquired from insects in these “domestic cycles,” and campaigns to eliminate the 
bugs, together with testing to prevent congenital cases and transmission in blood 
transfusions, have significantly reduced the incidence of Chagas disease. Antiparasitic 
treatment is most effective early, before irreversible damage occurs to the heart or 
gastrointestinal tract. 
Etiology 
Chagas disease results from infection with the protozoan parasite Trypanosoma 
cruzi, a member of the family Trypanosomatidae. Most strains of this parasite can be 
classified into two major groups, T. cruzi I and T. cruzi II, which can be separated 
further into various lineages (e.g., T. cruzi IIa). Lineages tend to be associated with 
certain host species, although this relationship is not absolute.  
Geographic Distribution 
T. cruzi can be found in the Americas from the U.S. to Chile and central 
Argentina. In the U.S., this parasite is thought to be endemic in approximately the 
southern half of the country, as well as in California. 
Transmission and Life Cycle 
Chagas disease is a vector-borne disease transmitted primarily by triatomine 
insects, which are also called reduviid insects, “kissing beetles/ bugs” or “assassin 
bugs.” More than 130 species of these insects appear to be capable of transmitting T. 
cruzi, with the most important species in the genera Triatoma, Rhodnius and 
Panstrongylus. The parasite usually completes its life cycle by cycling between an 
insect species and a mammalian species with which the insect lives in close 
association. The mammalian hosts include wildlife, domesticated animals and 
humans.  
In its mammalian host, T. cruzi can be found in the blood as trypomastigotes 
(extracellular nondividing forms) and in cells as amastigotes (replicative forms). 
When an insect takes a blood meal from an infected mammal, it ingests the 
trypomastigotes. After 2 to 4 weeks of development, some of the parasites migrate to 
the insect’s hindgut, where they are transformed into the infective metacyclic 
trypomastigotes. The insect defecates after it feeds, releasing the trypomastigotes in 
its feces. These parasites can enter the mammal’s body through mucous membranes 
or breaks in the skin. Scratching may inoculate trypomastigotes into the bite wound, 
or allow the parasites to enter through the scratches. Triatomine insect species that 
exhibit delayed defecation after feeding are less likely to transmit Chagas disease than 
species that defecate on the host. Humans and animals can also be infected if they eat 
either the insect or uncooked food that contains insect feces.  
There are three basic cycles of transmission for T. cruzi. In the sylvatic (wild) 
cycle, this organism cycles between wildlife and triatomine insects that live in 
sylvatic environments. Humans and domesticated animals are infected occasionally 
when they contact these bugs in the wild. Under some conditions, the insects may also 
invade houses or outbuildings when they are attracted to light, heat or certain odors, 
and may contaminate food. Wild triatomine insects can also be transported 
accidentally to human houses. The sylvatic cycle is responsible for relatively few 
cases of Chagas disease. It is the only cycle in the U.S. A domestic transmission cycle 
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also exists in Mexico and parts of Central and South 
America. In this cycle, some insect vectors have colonized 
primitive adobe, grass and thatched houses, resulting in 
transmission between humans and insects. Important 
species in the domestic cycle include Triatoma infestans, T. 
dimidiata and Rhodnius prolixus. Transmission cycles 
between insects and domesticated animals (peridomestic 
cycles) can also provide opportunities for the parasite to 
infect humans.  
T. cruzi is not spread between mammals by casual 
contact; however, it can be transmitted directly via blood 
(e.g., in a blood transfusion) and in donated organs. 
Carnivores can acquire this organism when they eat 
infected prey. Vertical transmission has been reported in 
dogs and other animals, both in utero and in the milk. 
Transmission in milk is very rare in humans, but 
transplacental transmission can occur at each pregnancy, 
and during all stages of infection. Laboratory infections 
usually occur when the parasites contact mucous 
membranes or broken skin, or are accidentally injected via 
needlestick injuries, but aerosol transmission might be 
possible in this setting. 
Disinfection 
T. cruzi is an obligate intracellular parasite. It is 
destroyed by several hours of exposure to direct sunlight or 
other harsh environments. T. cruzi is susceptible to many 
disinfectants including 1% sodium hypochlorite, 70% 
ethanol, iodine/alcohol solutions, glutaraldehyde and 
formaldehyde. It can be inactivated by moist heat (121°C 
for a minimum of 15 min) or dry heat (160 to 170°C for a 
minimum of an hour). 
Infections in Humans 
Incubation Period 
The incubation period is usually at least 5 to 14 days 
after exposure to triatomine insect feces, and 20 to 40 days 
after infection by blood transfusion. Many people do not 
become symptomatic until the chronic stage, which can 
occur 5 to 40 years after infection. 
Clinical Signs 
The acute phase is defined as the period during which 
the parasites can be found easily in the blood. Many people, 
particularly adults, are asymptomatic during this stage. The 
symptoms of the acute phase are highly variable and may 
include fever, headache, anorexia, malaise, myalgia, joint 
pain, weakness, nausea, vomiting, diarrhea, hepatomegaly, 
splenomegaly, and generalized or localized 
lymphadenopathy. Edema, either generalized or localized to 
the face and/or lower extremities, occurs in some cases. 
Sometimes, a chagoma (a localized painless induration) is 
seen where the parasite has entered through the skin. If 
entry occurs via the ocular mucous membranes, there may 
be painless edema of one or occasionally both eyes, often 
accompanied by conjunctivitis and enlargement of the local 
lymph nodes. This syndrome, which is called Romaña’s 
sign, usually persists for 1 to 2 months. Patients 
occasionally develop a rash, but this usually disappears 
within several days. In most cases, the clinical signs resolve 
within weeks to months without treatment; however, some 
acute cases can be fatal. Deaths are most likely to occur in 
young children and patients who are immunosuppressed 
(e.g., HIV-infected individuals), who may develop acute 
myocarditis or meningoencephalitis. 
The acute phase is usually followed by an 
asymptomatic period of varying length; this stage is called 
the indeterminate phase. During the indeterminate phase, 
the parasites disappear from the blood. Although estimates 
vary, approximately 70% to 90% of the patients in the 
indeterminate phase never become symptomatic. Most of 
the remaining patients enter the chronic phase after 5 to 15 
years, but in a few patients, the indeterminate phase can last 
as long as 40 years. 
The chronic phase is typically represented by organ 
failure, usually of the heart or digestive system. Heart 
disease, the most common form of chronic Chagas disease, 
may be characterized by arrhythmias and conduction 
abnormalities, cardiac failure, apical aneurisms, embolic 
disease including stroke or pulmonary embolism, and 
sudden death. Signs of isolated left heart failure may occur 
first. Biventricular congestive heart failure with peripheral 
edema, hepatomegaly, pulmonary congestion and dyspnea 
is common in the later stages. Some patients develop chest 
pains without evidence of coronary artery disease. 
Digestive system abnormalities lead to megaesophagus 
and/or megacolon, which can occur concurrently with heart 
disease. The symptoms of megaesophagus may include pain 
during swallowing, excessive salivation, regurgitation and 
chest pain. Dysphagia mainly occurs with dry, solid and cold 
food. Aspiration pneumonitis can be a sequela and there is an 
increased risk for cancer of the esophagus. In severe cases, 
there may be weight loss or cachexia, and the esophagus may 
rupture. The symptoms of megacolon include severe 
constipation, which can last for a few days to months, and 
abdominal pain that is often associated with episodes of 
constipation. The abdomen may be asymmetrically 
distended. Complications may include intestinal occlusion, 
volvulus, fecalomas, ulceration, or intestinal perforation with 
peritonitis. Patients with Chagas disease also have an 
increased chance of developing gastric ulcers or chronic 
gastritis, due to abnormalities in the stomach. Gall bladder 
abnormalities may include mega-gallbladder or cholelithiasis. 
Small intestinal dilatation is rare. 
Women who are infected with T. cruzi can give birth to 
infected children. Congenital infections may occur during 
any of the woman’s pregnancies, whether she is 
symptomatic or not. In congenitally infected infants, the 
most common symptoms are premature birth, 
hepatosplenomegaly, meningoencephalitis, changes in the 
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retina and signs of acute myocarditis/ cardiac insufficiency. 
Transplacental infections are also associated with abortions.  
Patients with AIDS suffer a more severe form of the 
disease with a high percentage of neurological and cardiac 
signs. Many of these patients develop T. cruzi brain 
abscesses, which are not seen in immunocompetent patients. 
HIV-infected individuals and others who are 
immunosuppressed, including those who receive organ 
transplants, are at risk for reactivation of T. cruzi replication. 
Communicability 
Chagas disease is not spread from person to person by 
casual contact, but infected humans can transmit the 
parasite to the insect vectors. Congenital infections occur in 
1-10% of infants born to infected mothers, and this may 
occur at any stage of the disease. Transmission through the 
milk is very rare. T. cruzi can also be spread in tissue 
transplants or blood transfusions. 
Diagnostic Tests 
Chagas disease can be diagnosed by microscopy, 
isolation of the parasite, serology or molecular techniques. 
Microscopic examination 
Light microscopy can sometimes detect T. cruzi in 
Giemsa or Wright stained samples of blood, cerebrospinal 
fluid or tissues. T. cruzi can be found in the heart, skeletal 
and smooth muscle cells, and the glial cells of the nervous 
system. It sometimes occurs in chagomas. In immuno-
compromised patients, parasites may also be detected in 
atypical sites such as the pericardial fluid, bone marrow, 
brain, skin and lymph nodes. Active parasitemia is much 
more likely to be found during the acute than the chronic 
stage. Either thick or thin blood smears may be examined, 
but parasite morphology is clearer in thin smears. Blood 
concentration techniques can increase the probability of 
finding the parasites; examination of the buffy coat is often 
used. T. cruzi can be difficult to distinguish from 
Trypanosoma rangeli, which is avirulent. 
Isolation of the agent 
T. cruzi can be cultured from heparinized blood 
samples or tissues. Various specialized media including 
liver infusion tryptose medium or Novy-MacNeal-Nicolle 
medium, as well as Vero cell lines can be used. Culture 
may take 1 to 6 months. The agent can also be isolated by 
inoculating the blood into a guinea pig, mouse or rat; this 
procedure is often successful in chronic cases. 
Xenodiagnosis is considered to be the gold standard where 
it is available. In xenodiagnosis, laboratory-reared, T. cruzi-
free triatomine insects are allowed to feed on an infected 
individual; the parasites may be found in the intestinal 
contents of the insect 1 to 2 months later. Because these 
methods of diagnosis are slow and labor-intensive, and 
require highly trained personnel, they are generally used 
only to confirm a diagnosis if other tests are inconclusive, 
in research, or to isolate strains of parasites. 
Serology 
Serology is most often used to diagnose chronic 
infections. Commonly used serological tests in humans 
include indirect immunofluorescence (IFA), 
hemagglutination and enzyme-linked immunosorbent 
assays (ELISAs). Other tests including 
radioimmunoprecipitation and complement fixation may 
also be used. Cross-reactions can occur with other parasites, 
particularly Leishmania species.  
Molecular techniques 
Polymerase chain reaction (PCR) techniques can be 
used for diagnosis. Immunoblotting (Western blotting) is 
another option. 
Treatment  
Acute Chagas disease can be treated with antiparasitic 
drugs. In the U.S., drugs may be available only under an 
Investigational New Drug protocol from the CDC Drug 
Service. Treatment of acute or congenital cases is 
recommended to prevent the development of chronic 
disease. Antiparasitic drugs are less effective in the 
indeterminate and chronic stages, and treatment 
recommendations may vary with the age of the patient and 
other factors. There are significant side effects with these 
drugs, which must be given long term.  
In the chronic stage, treatment of cardiomyopathy is 
mainly symptomatic and similar to the treatment of other 
causes of heart disease. A pacemaker may be necessary, 
and a heart transplant can be considered. Surgery, balloon 
dilation of the gastroesophageal junction and/or 
symptomatic relief may be used for chagasic 
megaesophagus or megacolon. 
Prevention 
Vaccines are not available for humans; however, 
precautions can be taken to reduce the risk of infection, 
particularly in countries where the prevalence of Chagas 
disease is high. Triatomine insects usually feed at night and 
withdraw to their hiding places in daylight. In endemic 
areas, houses can be improved by plastering walls, 
improving flooring and taking other measures to remove the 
cracks where these insects hide. Triatomine insects are 
often found in basements, which should be avoided. 
Sleeping inside a screened area, under a permethrin-
impregnated bed net, or in an air-conditioned room is 
safest. Bed nets should be tucked tightly under the mattress 
before dusk. Animal pens and storage areas should be kept 
away from homes. Regular spraying of insecticides in and 
around houses can reduce the number of insects, and in 
some cases, eliminate them.  
Some triatomine bugs such as Triatoma infestans and 
Rhodnius prolixus have adapted to human dwellings, and 
do not exist in the wild. These insects can be eliminated 
completely by control measures, greatly reducing the risk 
of Chagas disease. Since 1991, the Pan American Health 
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Organization and the World Health Organization have run 
a joint program to eliminate T. infestans, the most 
important vector for Chagas disease in humans. This 
program has decreased the distribution of this insect by 
more than 80%, although foci can still be found in some 
regions. Triatomine species that occur in sylvatic cycles 
but colonize human dwellings can also be controlled or 
eliminated by insecticides and other measures, but they 
may recolonize homes. Foods that might be contaminated 
should be cooked. 
Blood and organ donors should be screened to prevent 
transmission by these routes. In the U.S., transfused blood 
has been screened for Chagas disease since 2007. Pregnant 
women can be tested to identify cases where congenital 
transmission may occur, and the infant should be monitored 
and treated if necessary.  
People in occupational risk groups should take 
additional precautions. Veterinarians and technicians should 
protect their skin and mucous membranes from 
contamination with parasites in blood or tissues. This 
includes using gloves and/or other barriers while drawing 
blood samples from T. cruzi-infected animals, taking care 
of IV catheters or performing other invasive procedures. 
Needles and other “sharps” must be handled and disposed 
of properly to prevent needlestick injuries. Individuals who 
work with wildlife and hunters should also take 
precautions, especially when handling blood and tissues. 
Laboratory personnel should use appropriate personal 
protective equipment, including gloves and eye protection, 
while processing blood samples, cultures or infected 
insects. If an accidental exposure occurs, the site should be 
disinfected immediately if possible, and antiparasitic drugs 
may be given prophylactically. 
Travelers to areas where Chagas disease is common 
should wear thick clothing that covers as much of the body 
as possible; heavy long-sleeved shirts, long pants, socks and 
shoes are recommended. Sleeping in sub-standard housing 
should, if possible, be avoided.  
Morbidity and Mortality 
Chagas disease is most common among people who 
live in substandard housing. Most cases are acquired by 
exposure to insects in domestic or peridomestic cycles, or 
by congenital transmission. In some areas, outbreaks have 
been linked to foods such as fresh fruit juices contaminated 
by sylvatic triatomines. In endemic areas, many people 
become infected in childhood. In South and Central 
America, campaigns to control the vectors in the domestic 
cycle have significantly decreased the number of new 
human infections. Triatomine vectors for T. cruzi are 
present in the U.S.; however, only a few locally acquired, 
vector-borne cases have been diagnosed in people. The 
lower prevalence rate in the U.S. is mainly due to higher 
standards of living and the absence of triatomine species 
that are well adapted to living in human houses. In addition, 
some of the insects involved in sylvatic transmission in the 
U.S. exhibit delayed defecation after feeding, which may 
reduce the risk of transmission.  
The morbidity and mortality rates vary with the stage 
of the disease. Approximately 5% of people infected with 
T. cruzi develop acute symptoms. Estimates of the case 
fatality rate for acute Chagas disease range from less than 
5% to approximately 8%; among immunologically 
competent individuals; deaths occur mainly in young 
children with acute myocarditis or meningoencephalitis. 
The CDC estimates that 20-30% of humans infected with 
T. cruzi eventually develop chronic disease; estimates 
from other sources vary from 10% to 50%. The reason for 
the progression of disease in some patients but not others 
is unknown. It may be related to host genetic factors, the 
dose of the parasites, the number of inoculations, the 
strain of the parasite, and immunological or nutritional 
factors. Cardiac disease is often fatal. Occasionally, deaths 
are also caused by volvulus of a dilated sigmoid 
megacolon.  
Infections in Animals 
Species Affected 
Trypanosoma cruzi occurs in more than 100 species of 
mammals throughout the Americas; infections have been 
reported among carnivores including dogs and cats, as well 
as in pigs, goats, lagomorphs, rodents, marsupials, bats, 
xenarthra (anteaters, armadillos and sloths) and non-human 
primates. In the U.S., opossums, armadillos, raccoons, 
coyotes, rats, mice, squirrels, dogs and cats are among the 
most frequent hosts. Birds, reptiles and fish are not 
susceptible to infection. 
Incubation Period 
The incubation period for acute disease in dogs appears 
to be 5 to 42 days; in experimental infections, symptoms of 
acute heart disease are usually reported after 2 to 4 weeks. 
Like humans, some dogs may not develop clinical signs 
until the chronic stage, which occurs after a few years; the 
exact length of this period is not known. 
Clinical Signs 
Dogs 
Acute, latent and chronic stages of infection occur in 
experimentally infected dogs. Clinical signs reported in the 
acute stage include fever, anorexia, lethargy, an unkempt 
hair coat, lymphadenopathy, hepatomegaly and 
splenomegaly. Anorexia, diarrhea, ascites and/or weight 
loss may also be seen. Some dogs may have palpebral 
edema. Chagomas appear to be rare, but they have been 
reported in a few dogs inoculated with a South American 
strain of T. cruzi. Cardiac dysfunction can occur during the 
acute phase; acute myocarditis may cause arrhythmias or 
sudden collapse and death. After the acute phase, infected 
dogs enter the indeterminate (latent) stage, during which the 
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parasites are difficult to find and the animal is asymptomatic. 
The indeterminate stage can be as short as 27 days in some 
experimentally infected animals, but it seems to last for years 
in some natural infections. Congestive heart failure is the 
most common sign during the chronic stage. Right-sided 
heart failure usually occurs first. Eventually, dogs with 
heart disease develop chronic myocarditis with cardiac 
dilatation and arrhythmias. Sudden death can occur.  
Limited information is available from naturally 
infected dogs. In one retrospective study from Texas, 
sudden death was the most common presentation in more 
than 500 confirmed cases. Other common clinical signs 
included anorexia, lethargy, ascites, an enlarged heart, 
cardiac conduction disturbances and respiratory 
difficulties. Hepatomegaly, anemia, diarrhea, vomiting 
and edema were reported less often. Heart disease was 
the most common presentation in both puppies and 
adults. In Mexico, only mild disease was reported in 
naturally infected stray dogs, although ECG changes were 
seen in some of these animals. A limiting factor in the 
latter study is that stray dogs would be expected to have a 
relatively short lifespan, and may not have lived long 
enough to develop more severe signs.  
Atypical cases have also been reported in dogs. In 
one dog, the clinical signs included anorexia, lethargy, 
weight loss, generalized lymphadenopathy, fever and 
dependent, pitting edema, without cardiac signs or 
lesions. Neurologic signs such as limping or coma have 
occasionally been reported. One case of Chagas disease in a 
13-month-old Doberman pinscher presented as slowly 
progressive paraparesis with temporal, supraspinatus and 
infraspinatus muscle atrophy, bilateral enophthalmos, 
superficial inguinal lymphadenopathy, tachycardia with pulse 
deficits, and chorioretinitis. In addition to neurologic 
abnormalities in the hindlegs and forelegs, this dog had 
cranial nerve deficits and a delayed gag reflex. 
Experimentally infected dogs can develop 
histological abnormalities in the esophagus and stomach, 
but unlike humans, megaesophagus and megacolon have 
not been reported. 
Cats 
Symptomatic Chagas disease has been rarely described 
in cats. Reported clinical signs include fever, edema, weight 
loss and neurological signs such as convulsions and paresis.  
Other species 
There is little information about Chagas disease in 
other species, including wild animals. Mild, histologically 
evident myocarditis (without clinical signs of heart disease) 
has been reported at necropsy in infected wild raccoons and 
opossums. Naturally infected rats can develop arrhythmias 
and more severe cardiac lesions. Infertility, fetal losses, 
reduced birth weights, and early postnatal deaths have been 
reported in pregnant mice.  
 
Post Mortem Lesions      Click to view images 
In dogs, acute disease is characterized mainly by 
cardiac lesions, which are particularly prominent on the 
right side. The myocardium may be pale, and 
subendocardial and subepicardial hemorrhages are often 
present. Multiple yellowish-white spots and streaks, mainly 
involving the coronary groove, may be found in the heart. 
In addition, there may be secondary pulmonary edema, 
congestion in the liver, spleen and kidneys, and a modified 
transudate in the peritoneal cavity. Pericardial effusion has 
been reported in some naturally infected dogs. Gross 
lesions may be absent in some infected animals.  
In chronic Chagas disease, the heart is bilaterally 
enlarged and flaccid, with thinning of areas in the 
ventricular walls. Atypical cases without cardiac lesions 
have also been reported. 
Mild myocarditis (multifocal interstitial inflammation) 
has been reported in wild raccoons and opossums at 
necropsy. 
Communicability 
Chagas disease is not contagious during casual 
contact, but the parasite can be transmitted in blood or by 
contact with tissues. Carnivores can be infected if they eat 
T. cruzi-contaminated tissues. Many species of animals, 
including dogs, can serve as amplifying hosts, and infect 
the insect vectors. Vertical transmission can also occur in 
some animals. 
Diagnostic Tests 
Chagas disease can be diagnosed by microscopy, isolation 
of the parasite, serology and molecular techniques. 
Microscopic examination 
A presumptive diagnosis can be made if T. cruzi is 
observed by light microscopy in a stained blood smear or 
buffy coat sample, or in tissues such as the heart. The 
trypomastigotes occur as either short, broad forms or long, 
thin forms in the blood; in stained preparations, they form a 
C-shape. Amastigotes, which are found inside cells, are 
round or ovoid, and 1.5-4 µm in diameter. Differentiating T. 
cruzi from the morphologically similar, non-pathogenic 
species T. rangeli is difficult. 
Isolation of the agent 
T. cruzi can be cultured from blood samples or tissues; 
culture is usually more successful in the acute stage. This 
organism often occurs in the myocardium, but it can also 
be isolated from other organs such as the lymph nodes, 
liver, gastrointestinal tract, brain, cerebrospinal fluid and 
adrenal gland. Various specialized media including liver 
infusion tryptose medium or Novy-MacNeal-Nicolle 
medium, as well as Vero cell lines may be used. The agent 
may also be isolated by inoculating blood into a guinea 
pig, mouse or rat. Xenodiagnosis is considered to be one 
of the most accurate tests for Chagas disease in South 
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America, but it is of little practical importance for 
veterinarians in the U.S. Isolation of the agent may take 1 
to 6 months, and requires highly trained personnel. 
Serology 
Indirect immunofluorescence is the most commonly 
used serological test. Other assays include radio-immuno-
precipitation, direct and indirect hemagglutination, 
complement fixation and ELISAs. Cross-reactions can occur 
with other parasites, particularly Leishmania species. 
Molecular techniques 
Molecular detection methods including PCR and 
western blot (immunoblot) analysis techniques can detect T. 
cruzi DNA in tissues and blood. 
Treatment 
Occasionally, dogs have been treated with anti-
parasitic drugs. These drugs appear to be more effective in 
the early stages; by the time of diagnosis, treatment may be 
too late to prevent the progression of the disease. 
Prevention 
Dogs and cats should not be allowed to eat tissues from 
potentially infected wild animals. Strict indoor housing in 
well-constructed homes or other facilities reduces the risk 
of infection. Housing animals indoors at night, when 
triatomine insects are active, may also be helpful. Residual 
insecticides sprayed regularly in kennels and surrounding 
structures may decrease the number of insect vectors. In 
breeding kennels, testing bitches for T. cruzi-might also 
decrease the incidence of Chagas disease by reducing 
vertical transmission. No vaccines are available. 
Morbidity and Mortality 
The prevalence rate can be high among wildlife in 
endemic areas. Surveys of wildlife in the U.S., conducted 
mainly in raccoons and opossums, have reported prevalence 
rates from 2% to 62%. In one study, 19 of 134 coyotes in 
Texas had antibodies to T. cruzi. In the U.S., the reported 
seroprevalence rates in dogs from Texas, Oklahoma, 
Louisiana, Georgia and other southern states vary from 
1.1% to 8.8%. Over a 15-year period, more than 500 
clinical cases of Chagas disease were reported among dogs 
in Texas, suggesting that this disease occurs regularly in 
some areas. In the Yucatan region of Mexico, one study 
reported that 10-14% of dogs were seropositive, but when 
both serology and PCR were used, the prevalence as high as 
17%. The infection rate is highest among dogs that are 
regularly exposed to wildlife and insect vectors. Cats are 
frequently infected with T. cruzi in South America. 
There is little information on the morbidity and 
mortality rates in dogs, except in experimentally infected 
animals, where these rates are high. In one study, 13 of 26 
dogs infected with blood trypomastigotes died during the 
acute phase. In another, 26 of 38 dogs died during the 
acute phase, while the 12 survivors developed chronic 
disease and lived for 1 to 2 years. In a study using North 
American strains of T. cruzi from armadillos or opossums, 
7 of 13 dogs died or were euthanized due to the severity of 
acute disease. Based on human data, some sources suggest 
that approximately 5% of naturally infected animals 
would be expected to develop symptoms during the acute 
stage. In naturally infected dogs with chronic cardiac 
disease, the survival time after diagnosis ranged from 0 
months to 5 years. 
Internet Resources 
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/chagas/ 
Public Health Agency of Canada - Disease Information. 
American Trypanosomiasis or Chagas Disease 
http://www.phac-aspc.gc.ca/tmp-
pmv/info/am_trypan_e.html 
Public Health Agency of Canada - Transfusion Transmitted 
Diseases/Infections 
http://www.phac-aspc.gc.ca/hcai-iamss/tti-
it/ttdi_e.html#chagas 
Medical Microbiology 
http://www.ncbi.nlm.nih.gov/books/NBK7627/ 
The Merck Manual 
http://www.merck.com/pubs/mmanual/ 
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp 
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